178 related articles for article (PubMed ID: 28325285)
1. Targeted Expression of miR-7 Operated by TTF-1 Promoter Inhibited the Growth of Human Lung Cancer through the NDUFA4 Pathway.
Lei L; Chen C; Zhao J; Wang H; Guo M; Zhou Y; Luo J; Zhang J; Xu L
Mol Ther Nucleic Acids; 2017 Mar; 6():183-197. PubMed ID: 28325285
[TBL] [Abstract][Full Text] [Related]
2. Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.
Chen S; Guan L; Zhao X; Yang J; Chen L; Guo M; Zhao J; Chen C; Zhou Y; Han Y; Xu L
J Zhejiang Univ Sci B; 2022 Nov; 23(11):915-930. PubMed ID: 36379611
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
4. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
6. [Over-expressed microRNA-7 inhibits the growth of human lung cancer cells via suppressing CGGBP1 expression].
Hu Y; Liao Z; Chen C; Qin N; Zheng J; Tian D; Li Y; Zhu S; Luo J; Xu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):125-30. PubMed ID: 24491049
[TBL] [Abstract][Full Text] [Related]
7. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
8. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
[TBL] [Abstract][Full Text] [Related]
9. Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer.
Zhao J; Wang K; Liao Z; Li Y; Yang H; Chen C; Zhou YA; Tao Y; Guo M; Ren T; Xu L
Mol Clin Oncol; 2015 Nov; 3(6):1329-1336. PubMed ID: 26807243
[TBL] [Abstract][Full Text] [Related]
10. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
Wang C; Li S; Xu J; Niu W; Li S
Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
12. The novel hsa-miR-12528 regulates tumourigenesis and metastasis through hypo-phosphorylation of AKT cascade by targeting IGF-1R in human lung cancer.
Jeon SH; Yoo JK; Kim CM; Lim ES; Lee SJ; Lee JM; Oh SH; Kim JK
Cell Death Dis; 2018 May; 9(5):493. PubMed ID: 29712908
[TBL] [Abstract][Full Text] [Related]
13. MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.
Shi L; Zhang B; Sun X; Lu S; Liu Z; Liu Y; Li H; Wang L; Wang X; Zhao C
Br J Cancer; 2014 Dec; 111(12):2316-27. PubMed ID: 25412236
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Fang Y; Xue JL; Shen Q; Chen J; Tian L
Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
[TBL] [Abstract][Full Text] [Related]
15. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.
Wu J; Tan X; Lin J; Yuan L; Chen J; Qiu L; Huang W
Hum Gene Ther; 2017 May; 28(5):415-427. PubMed ID: 28042945
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A.
Wang L; Yao J; Sun H; He K; Tong D; Song T; Huang C
Oncol Lett; 2017 Jan; 13(1):329-338. PubMed ID: 28123563
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling.
Qu J; Li M; An J; Zhao B; Zhong W; Gu Q; Cao L; Yang H; Hu C
Int J Oncol; 2015 Dec; 47(6):2141-52. PubMed ID: 26459797
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo.
Jiang Q; Yuan Y; Gong Y; Luo X; Su X; Hu X; Zhu W
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2951-2967. PubMed ID: 31654121
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
Cui S; Yang X; Zhang L; Zhao Y; Yan W
Biochem Biophys Res Commun; 2018 Nov; 506(1):251-258. PubMed ID: 30348529
[TBL] [Abstract][Full Text] [Related]
20. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]